Fingerprint
Dive into the research topics of 'Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer
Henry M. Rosevear, Andrew J. Lightfoot, Thomas S. Griffith
Research output: Contribution to journal › Review article › peer-review
31
Scopus
citations